D-0298-2021 Class III Terminated
FDA drug recall D-0298-2021 was initiated by Jubilant Cadista Pharmaceuticals, Inc. on Feb 19, 2021 and is designated Class III. Reason for recall: Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card. The recall status is terminated (terminated Nov 15, 2022). Affected quantity: 635,400 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 10, 2021
- Initiation Date
- Feb 19, 2021
- Termination Date
- Nov 15, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 635,400 cartons
Product description
Methylprednisolone Tablets USP, 4 MG, packaged in a 21-count blister pack, Rx only, Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-001-03
Reason for recall
Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card.
Distribution pattern
USA nationwide, including Puerto Rico.
Code information
Lot #: 20K0043P, 20K0044P, 20K0042P, Exp 08/2022; 20L0026P, 20L0027P, 20L0028P, 20L0029P, 20L0030P, Exp 09/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0298-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026